GlassScriptPhysician profile
Natalie Colome
NPI 1710282157
$9,522.14
in general payments reported to CMS, 2019-2025
27 companies · $2,432 in 2025
The $2,432 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $118 · 2022: $2,969 · 2023: $1,331 · 2024: $2,671 · 2025: $2,432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,422 · Education: $11.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,422.46 |
| Education | $11.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $3,012.53 | 2022-2024 | Venclose Maven Catheter |
| Merck Sharp & Dohme LLC | $817.81 | 2023-2025 | Verquvo, Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $650.42 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $632.13 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $553.49 | 2022-2025 | Wainua, Farxiga, Lokelma |
| Shockwave Medical, INC | $505.15 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $447.28 | 2023-2025 | |
| Amgen INC. | $438.61 | 2023-2025 | Repatha, Repatha, Otezla |
| Abbott Laboratories | $350.21 | 2024-2025 | Jot Dx, Aveir |
| Boehringer Ingelheim Pharmaceuticals, INC. | $318.86 | 2021-2025 | Jardiance |
| Medtronic, INC. | $269.89 | 2025 | Venaseal, Mycarelink |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $261.17 | 2023-2025 | Lifevest |
| Abiomed | $215.73 | 2024-2025 | Impella |
| Esperion Therapeutics, INC. | $195.12 | 2024-2025 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $171.94 | 2023-2025 | Eliquis, Camzyos |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $161.14 | 2024-2025 | Evkeeza |
| Boston Scientific Corporation | $97.70 | 2025 | Varithena Administration Pack |
| Novo Nordisk INC | $70.51 | 2025 | Wegovy, Ozempic |
| Philips North America LLC | $68.85 | 2024-2025 | (Ck7) Extended Holter, Extended Holter |
| Baxter Healthcare | $66.60 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Bridgebio Pharma, INC. | $65.00 | 2025 | Attruby |
| Pfizer INC. | $44.13 | 2023-2025 | |
| Scpharmaceuticals INC. | $27.95 | 2024 | |
| Amarin Pharma, INC. | $22.38 | 2022 | |
| Lilly USA, LLC | $21.79 | 2025 | Zepbound |
| Lexicon Pharmaceuticals, INC. | $18.36 | 2023 | Inpefa |
| Inspire Medical Systems, INC. | $17.39 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Colome listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.